Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries ADR (NY: TEVA )

17.08 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries ADR

< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Juvenile Investing Mob
Tech stocks did well in Europe but not in the US. The data are unconvincing. 
Via Talk Markets
FDA surprise
The big news out of China is that its import purchases of copper and iron sagged last month because its export markets are far less strong than earlier this year. 
Via Talk Markets
Exposures Product Safety
A Better Switch
Today the US market decided to rise because President Biden is pondering not linking his infrastructure project to a corporate tax increase. 
Via Talk Markets
Fan Hit
The 10-yr US treasury yield rose to 1.6% again. Later in the day, a rally was attempted, mostly for the meme shares. 
Via Talk Markets
New Clinical and Real-World Data Evaluating Efficacy of AJOVY® (fremanezumab-vfrm) Injection Presented at 2021 American Headache Society (AHS) Annual Meeting
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2021 American Headache Society (AHS) Annual Meeting, Showcasing Teva’s Longstanding Heritage in the Management of Migraine
From Teva Pharmaceutical Industries Limited
Via Business Wire
A Catch-Up Day
OPEC had a virtual meeting about rising demand for oil and rising demand that oil companies cut their carbon footprint. 
Via Talk Markets
3 Cheap Pharmaceutical Stocks to Grab Now
The pharmaceutical industry has been the beneficiary of significant investor attention amid the COVID-19 pandemic as society turned to its products to fight the coronavirus. 
Via Talk Markets
Exposures COVID-19
Good Times For Gold
Gold is rising some more, in part as an alternative to crypto. 
Via Talk Markets
The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB)... 
Via Benzinga
Exposures COVID-19
Sterling At Five-Year High
Today markets are mixed because of currency factors, with sterling bullishness against the dollar and the euro. 
Via Talk Markets
Better Mood Day
The US Treasury plans to require IRS reporting on US cryptocurrency trades of $10,000 and up to prevent tax evasion. 
Via Talk Markets
The Companies Tackling A Global Health Crisis
Via FinancialNewsMedia
Teva Announces the U.S. Launch of the First Generic Version of THIOLA® (tiopronin) tablets
From Teva Pharmaceutical Industries Limited
Via Business Wire
Friday Of The Heavy Week
There is nothing like a pending weekend to push Wall Street into recuperation and this worked today 
Via Talk Markets
A Down Day
The tech wreck continues because inflation will hurt the costly stock sector more than others. 
Via Talk Markets
Heavy Global Erosion
It is an everything-down day. Even the news is down because commenters are being careful. 
Via Talk Markets
Gold Up Four Days In A Row
The dollar is at a nearly 3 month low. 
Via Talk Markets
Teva to Highlight Research in Respiratory Care at Upcoming 2021 American Thoracic Society International Conference
From Teva Pharmaceutical Industries Limited
Via Business Wire
Calm Markets Day
Despite seriously disappointing April jobless numbers, markets are gaining all the same. 
Via Talk Markets
Understanding Teva Pharmaceutical Indus's Unusual Options Activity
Understanding Teva Pharmaceutical Indus's Unusual Options Activity On Thursday, shares of Teva Pharmaceutical Indus (NYSE:TEVA) saw unusual options activity. After the option... 
Via Benzinga
Finns and Danes
Stock markets are still uncertain whether to rise or fall after the Tuesday debacle. 
Via Talk Markets
Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report
From Teva Pharmaceutical Industries Limited
Via Business Wire
Teva Announces Launch of its Generic Erythromycin Tablets USP, Used to Treat or Prevent a Variety of Bacterial Infections, in the United States
From Teva Pharmaceutical Industries Limited
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2021
Upgrades For Genuine Parts Co (NYSE:GPC), Goldman Sachs upgraded the previous rating of Sell to Neutral. In the first quarter, Genuine Parts showed an EPS of $1.50,... 
Via Benzinga
Monday Markets Unhinged
Today's stock market is somewhat unhinged because so many foreign markets are shut for a bank holiday: Britain, China, Thailand, Japan. 
Via Talk Markets
9 Health Care Stocks Showing Unusual Options Activity In Today's Session
Here's the list of some unusual options activity happening in today's session: Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest... 
Via Benzinga
Teva to Present New Long-Term AUSTEDO® (deutetrabenazine) Tablets Data at American Psychiatric Association Annual Meeting
From Teva Pharmaceutical Industries Limited
Via Business Wire
Another Heavy News Day
For whatever it is worth, markets seem keen on the proposed measures, boosted by a nicely lower level of new unemployment insurance claims last week. 
Via Talk Markets
Teva Announces the Launch of the First Generic Version of Absorica® (isotretinoin) Capsules, for the Treatment of Severe Recalcitrant Nodular Acne in Patients 12 Years of Age and Older, in the United States
From Teva Pharmaceutical Industries Limited
Via Business Wire
< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.